These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 33998660

  • 1. Lacosamide add-on therapy for focal epilepsy.
    Babar RK, Bresnahan R, Gillespie CS, Michael BD.
    Cochrane Database Syst Rev; 2021 May 17; 5(5):CD008841. PubMed ID: 33998660
    [Abstract] [Full Text] [Related]

  • 2. Lacosamide add-on therapy for partial epilepsy.
    Weston J, Shukralla A, McKay AJ, Marson AG.
    Cochrane Database Syst Rev; 2015 Jun 16; (6):CD008841. PubMed ID: 26077821
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Marson AG.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD005612. PubMed ID: 35349176
    [Abstract] [Full Text] [Related]

  • 4. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Hemming K, Marson AG.
    Cochrane Database Syst Rev; 2019 Jul 09; 7(7):CD005612. PubMed ID: 31287157
    [Abstract] [Full Text] [Related]

  • 5. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M, Al-Bachari S, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2021 Jan 12; 1(1):CD001415. PubMed ID: 33434292
    [Abstract] [Full Text] [Related]

  • 6. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Ramaratnam S, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 20; 3(3):CD001909. PubMed ID: 32196639
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ.
    Cochrane Database Syst Rev; 2021 Dec 06; 12(12):CD012121. PubMed ID: 34870321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rufinamide add-on therapy for drug-resistant epilepsy.
    Panebianco M, Prabhakar H, Marson AG.
    Cochrane Database Syst Rev; 2020 Nov 08; 11(11):CD011772. PubMed ID: 33179247
    [Abstract] [Full Text] [Related]

  • 12. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R, Atim-Oluk M, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 04; 3(3):CD012433. PubMed ID: 32129501
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R, Panebianco M, Marson AG.
    Cochrane Database Syst Rev; 2022 Mar 14; 3(3):CD011501. PubMed ID: 35285519
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.